$36.61
+1.41 (+4.01%)
Performance
1D
—
1W
—
1M
—
3M
+6.39%
6M
+60.57%
1Y
+146.20%
YTD
+16.59%
Open$35.57
Previous Close$35.20
Day High$37.43
Day Low$35.57
52W High$46.67
52W Low$11.26
Volume—
Avg Volume1.81M
Market Cap3.05B
P/E Ratio—
EPS$-1.43
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.31
Below
SMA 200
$25.48
Above
RSI (14)
31.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+17.9% upside
Current
$36.61
$36.61
Target
$43.17
$43.17
$30.71
$43.17 avg
$51.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 12.60M | 12.24M | 783.80M |
| Net Income | -117,369,792 | -102,665,771 | 150.56M |
| Profit Margin | -931.7% | -885.1% | 19.2% |
| EBITDA | -112,941,947 | -104,281,125 | 266.89M |
| Free Cash Flow | — | — | 76.52M |
| Rev Growth | +2.9% | +2.9% | +0.6% |
| Debt/Equity | 1.49 | 1.49 | 0.76 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |